Abstract
Growth hormone secretagogues (GHS) consist of a series of small enkephalin derived peptides identified as growth hormone-releasing peptides (GHRPs) (Bowers, 1993) and non-peptidyl derivatives modeled from GHRPs (Smith et al., 1997). To this class of compounds is recently added a new member, ghrelin, an endogenous 28 amino acid polypeptide isolated from the stomach (Kojima et al., 1999). GHS share a common activity in stimulating the release of growth hormone (GH) from the pituitary in several animal species and in man (Ghigo et al., 2001). The GH release is mediated through the binding of GHS to a G protein-coupled receptor identified by expression cloning as GHS-Ria or ghrelin receptor, for which mRNA expression as well as protein receptor localization are mainly confined to the hypothalamus and the pituitary (Howard et al., 1996).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bedendi I., Gallo M.P., Malan D., Levi R.C. and Alloatti G. (2001). Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle. Life Sci, 69, 2189–2201.
Berti F., Rossoni G., and De Gennaro Colonna V. (1999). Hexarelin, a synthetic growth hormone secretagogue, exhibits protectant activity in experimental myocardial ischemia and reperfusion. In Growth hormone secretagogues, eds E. Ghigo, M. Boghen, F.F. Casanueva and C. Dieguez, pp. 301–314. New York, Elsevier Science.
Bisi G., Podio V.,Valetto M.R., Broglio F., Bertuccio G., Del Rio G.,Arvat E., Boghen M.F., Deghenghi R., Muccioli G.,Ong H. and Ghigo E. (1999). Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. J Endocrinol Invest, 22, 266–272.
Bodart V., Bouchard J.F., McNicoll N., Escher E., Carriere P., Ghigo E., Sejlitz T., Sirois M.G., Lamontagne D. and Ong, H. (1999). Identification and characterization of a new growth hormone-releasing peptide receptor in the heart. Circ Res, 85, 796–802.
Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., Sejlitz T., Escher E., Silverstein R.L., Lamontagne D. and Ong, H. (2002). CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res, 90, 844–849
Bouchard J.F. and Lamontagne D. (1996). Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury. Am J Physiol, 271, H1801–H186.
Bowers C.Y. (1993). GH-releasing peptides-structure and kinetics. J Pediatr Endocrinol, 6, 21–31.
Cassoni P., Papotti M., Ghè C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E. and Muccioli G. (2001). Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab, 86, 1738–1745.
Date Y., Nakazato M., Hashiguchi S., Dezaki K., Mondal M.S., Hosoda H., Kojima M., Kangawa K.,Arima T., Matsuo H., Yada T.and Matsukura S. (2002). Ghrelin is present in pancreatic a-cells of humans and rats and stimulates insulin secretion. Diabetes, 51, 124–129.
De Gennaro Colonna V., Rossoni G., Bernareggi M., Muller E.E. and Berti F. (1997). Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin. Eur J Pharmacol, 334, 201–207.
De Gennaro Colonna V., Rossoni G., Cocchi D., Rigamonti A.E., Berti F.and Muller E.E. (2000). Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats. J Endocrinol, 166, 529–536.
Febbraio M., Hajjar D.P., and Silverstein R.L. (2001). CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest, 108, 785–791.
Filigheddu N., Fubini A., Baldanzi G., Cutrupi S., Ghe C., Catapano F., Broglio F., Bosia A., Papotti M., Muccioli G., Ghigo E., Deghenghi R. and Graziani A. (2001). Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death. Endocrine, 14, 113–119
Ghigo E., Arvat E., Giordano R., Broglio F.,Gianotti L., Maccario M., Bisi G., Graziani A., Papotti M., Muccioli G., Deghenghi R. and Camanni F. (2001). Biologic activ ities of growth hormone secretagogues in humans. Endocrine, 14, 87–93.
Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. (2002). The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab, 87, 2988.
Hattori N., Saito T., Yagyu T., Jiang B.-H., Kitagawa K., and Inagaki C. (2001). GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab, 86, 4284–4291.
Howard A.D., Feighner S., Cully D.F., Arena J.P., Liberator P.A., Resenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C, Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Mellilo D.G. and Van der Ploeg L.H. (1996). A receptor in pituitary and hypothalamus that functions in growth hormone release. Science, 273, 974–977
Katugampola S.D., Pallikaros Z. and Davenport M. (2001). 125I-His(9)-ghrelin, a novel radiologand for localizing GHS orphan receptors in human and rat tissue: up-regula-tion of receptors with atherosclerosis. Br J Pharmacol, 134, 143–149.
Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H. and Kangawa K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656–660.
Locatelli V., Rossoni G., Schweiger R, Torsello A., De Gennaro C.V., Bernareggi M., Deghenghi R., Muller E.E. and Berti F. (1999). Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology, 140, 4024–4031.
MacAndrew J.T., Ellery S.S., Parry M.A., Pan L.C. and Black S.C. (2001). Efficacy of a growth hormone-releasing peptide mimetic in cardiac ischemia/reperfusion injury. Eur J Pharmacol, 432, 195–202.
Muccioli G., Broglio F., Valetto M.R., Ghè C, Catapano F., Graziani A., Papotti M., Bisi G., Deghenghi R. and Ghigo E. (2000). Growth hormone-releasing peptides and the cardiovascular system. Ann Endocrinol, 61, 27–31.
Musters R.J., van der Meulen E.T., Zuidwijk M., Muller A., Simonides W.S., Banerjee A. and van Hardeveld C. (1999). PKC-dependent preconditionning with norepinephrine protects sarcoplasmic reticulum function in rat trabeculae following metabolic inhibition. J Mol Cell Cardiol, 31, 1083–1094.
Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y. and Kangawa K. (2001). Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regulatory Integrative Comp Physiol, 280, R1483–R1487.
Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H. and Kangawa K. (2002). Vasodilatory effect of ghrelin and endogenous peptides from the stomach. J Cardiovasc Pharmacol, 39, 779–783.
Ong H., Bodart V, McNicoll N., Lamontagne D. and Bouchard J.E (1998a). Binding sites for growth hormone-releasing peptide. Growth Horm IGF Res, 8 (Suppl B), 137–140.
Ong H, McNicoll N., Escher E., Collu R., Deghenghi R., Locatelli V, Ghigo E., Muccioli G., Boghen M. and Nilsson A. (1998b). Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffmity labeling. Endocrinology, 139, 432–435.
Papotti M., Ghè C, Cassoni P., Catapano F., Deghenghi R., Ghigo E. and Muccioli G. (2000). Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab, 85, 3803–3807.
Rossoni G., De Gennaro Colonna V., Bernareggi M., Polvani G.L., Muller E.E. and Berti F. (1998). Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J Cardiovasc Phamacol, 32, 260–265.
Smith R.G., Van der Ploeg L.H.T., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J. Jr, Fisher M.H., Nargund R.P. and Patchett A.A. (1997). Peptidomimetic regulation of growth hormone secretion. Endoc Rev, 18, 621–645.
Tivesten Å., Bollano E., Caidahl K., Kujacic V, Sun X.Y., Hedner T., Hjalmarson Å., Bengtsson B.-Å. and Isgaard J. (2000). The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology, 141, 60–66.
Tschöp M., Smiley D.L. and Heiman M.L. (2000). Ghrelin induces adiposity in rodents. Nature, 407,908–913.
Weekers R, Van Herck E., Isgaard J. and Van den Berghe G. (2000). Pretreatment with growth hormone-releasing peptide-2 directly protects against the diastolic dysfunction of myocardial stunning in an isolated, blood-perfused rabbit heart model. Endocrinology, 141, 3993–3999.
Wiley K.E. and Davenport A.P. (2002). Comparison of vasodilators in human mammary arteries: ghrelin is a potent physiological antagonist of endothelin. Br J Pharmacol, 136, 1146–1152.
Wren A.A., Small C.J., Abbott CR., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A. and Bloom S.R. (2001). Ghrelin causes hyperpha-gia and obesity in rats. Diabetes, 50, 2540–2547.
Wu D., Clarke I.J. and Chen C. (1997). The role of protein kinase C (PKC) in growth hormone (GH) secretion induced by GH-releasing factor (GRF) and GH-releasing peptides (GHRP) in cultured ovine somatotrophs. J Endocrinol, 154, 219–230.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Italia
About this paper
Cite this paper
Ong, H., Lamontagne, D., Demers, A., Marleau, S. (2003). Physiological Function of Growth Hormone Secretagogue Receptors in the Cardiovascular System. In: Müller, E.E. (eds) Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance. Springer, Milano. https://doi.org/10.1007/978-88-470-2085-6_12
Download citation
DOI: https://doi.org/10.1007/978-88-470-2085-6_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2170-9
Online ISBN: 978-88-470-2085-6
eBook Packages: Springer Book Archive